Website Banner Farcast Bio.png

WE KNOW HUMAN TUMORS INSIDE OUT

 

Farcast Tumor Microdynamics Platform

Farcast's living human tumor technology harvests fresh human tumors, and uses proprietary methods to fragment and culture them ex-vivo


Preservation of the entire tumor architecture along with near native functional and spatial fidelity enables the evaluation of true treatment responses in realistic human tumor microenvironments

Multi-factor microdynamics data are combined with sophisticated AI (artificial intelligence) to create highly precise treatment response signatures

The Farcast system leads to higher precision compared to any conventional pre-clinical models and

helps understand the full complexities of human cancer

iStock-1385929874.png

TruNet

Trusted relationships with cancer centers who share our vision to help patients do better

iStock-1385673803.png

TruSign

Unique signatures for precise understanding of therapeutic response

LA1_CD68op520_CD3_op570_CD8_op690_panCKAF750_20X -10.bmp

TruTumor Culture

 Preserving native spatial contexture in human tumor microenvironment

 Representing tumor heterogeneity

 Simultaneous comparison of multiple therapies for every patient tumor

 Orthogonal assays to assess response

 panCK CD8 CD3 CD68 Nucleus

Farcast proprietary image 

Farcast Is Helping Unravel The Truths of Tumor Microdynamics

SITC_annual_2022_edited_edited.jpg
37TH ANNUAL SITC 2022: 
Demonstrating the role of spatial contexture in determining response to immune check point inhibitors using a tumor histo-culture platform
SITC TME 2022: Elucidating the difference between peripheral blood immune cell and Intratumoral Immune Cells (IICs) 
AACR 2022: Differential T-cell Response in different indications